Advertisement

Topics

Ganciclovir and IL-6 Levels Among CMV-Seropositive Critically Ill Adults

20:00 EDT 21 Aug 2017 | JAMA

This randomized clinical trial examines whether ganciclovir prophylaxis reduces plasma interleukin 6 levels in cytomegalovirus-seropositive adults who are critically ill.

Original Article: Ganciclovir and IL-6 Levels Among CMV-Seropositive Critically Ill Adults

NEXT ARTICLE

More From BioPortfolio on "Ganciclovir and IL-6 Levels Among CMV-Seropositive Critically Ill Adults"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...